Ftse Mib
33.771,75
0,07%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.405,93
2,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zynerba Pharmaceuticals Inc (ZYNE) Zynerba Pharmaceuticals Inc (ZYNE) Notizie

Zynerba Pharmaceuticals Inc

ZYNE
1,30
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/2/202401:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/10/202322:48EDGAR2Form 15-12G - Securities registration termination [Section..
12/10/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
11/10/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202315:27EDGAR2Form POS AM - Post-Effective amendments for registration..
11/10/202315:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/10/202314:56EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/10/202314:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/10/202314:17EDGAR2Form 8-K - Current report
11/10/202314:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
04/10/202323:29EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
04/10/202322:05GLOBEImportant Information for Zynerba Pharmaceuticals..
29/9/202315:00GLOBEZynerba Pharmaceuticals Stockholders Reminded to Tender..
27/9/202314:25EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
27/9/202314:12EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
27/9/202314:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
15/9/202314:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/9/202322:59EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
14/9/202322:16EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/9/202322:15GLOBEZynerba Pharmaceuticals Presents Positive Data from Phase 2..
14/9/202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/8/202322:05EDGAR2Form 8-K - Current report
28/8/202315:05EDGAR2Form SC 14D9 - Solicitation, recommendation statements
28/8/202314:23EDGAR2Form SC TO-T - Tender offer statement by Third Party
24/8/202323:23EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/8/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202323:29EDGAR2Form SC TO-C - Written communication relating to an issuer..
14/8/202323:26EDGAR2Form SC TO-C - Written communication relating to an issuer..
14/8/202323:20EDGAR2Form SC14D9C - Written communication relating to third party..
14/8/202313:45EDGAR2Form SC14D9C - Written communication relating to third party..
14/8/202313:42EDGAR2Form 8-K - Current report
14/8/202313:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:30PRNUSHARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
08/8/202322:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/8/202322:05GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
25/7/202323:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/7/202323:18GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
28/6/202322:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/6/202322:05GLOBEZynerba Pharmaceuticals Announces Further Adjournment of..
20/6/202313:00GLOBEZynerba Pharmaceuticals to Present at the H.C. Wainwright..
13/6/202322:05GLOBEZynerba Pharmaceuticals Announces Partial Adjournment of..
23/5/202313:00GLOBEZynerba Pharmaceuticals Announces Podium and Poster..
15/5/202313:00GLOBEZynerba Pharmaceuticals Reports First Quarter 2023 Financial..
Apertura: Min: Max:
Chiusura: 1,30

La tua Cronologia

NASDAQ
ZYNE
Zynerba Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network